Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Kudinoside D
Cat. No.:
0225LY-0836
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Kudinoside D utilizes the AMPK signaling pathway to modulate adipogenic transcription factors, thereby exerting anti-adipogenic effects.
Synonym:
Kudinoside D; 173792-61-5; AKOS040760505
CAS No.:
173792-61-5
Compound CID:
131849705
Formula:
C47H72O17
Formula Weight:
909.06
Specification
Relative Density:
1.43 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Kudinoside D can be used in metabolic studies to explore its role in regulating lipid accumulation and glucose transport.
Library Information
Target:
PPAR; AMPK; LDL
Receptor:
PPAR; AMPK; LDL
Pathways:
DNA damage/DNA repair; Metabolism; Chromatin/Epigenetic; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-11
Plate Location:
g5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
60 mg/mL; 66 mM
